Feedback / Questions
IMA203 - Immatics
https://www.globenewswire.com/news-release/2025/05/31/3091403/0/en/Immatics-IMA203-PRAME-Cell-Therapy-Data-Presented-at-2025-ASCO-Annual-Meeting-Continues-to-Show-Strong-Anti-tumor-Activity-and-Durability-in-Patients-with-Metastatic-Melanoma.html
May 31, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next